Home Categories Info Network

Clinical Trial For Possible Covid-19 Treatment Now Open In Edmonton, Calgary

Permalink Report to webmaster


Clinical trial for possible COVID-19 treatment now open in Edmonton, Calgary

By Julia Wong Global News

Posted July 31, 2020 4:44 pm

FILE - In this Feb. 18, 2020, file photo, Dr. Zhou Min, a recovered COVID-19 patient who has passed his 14-day quarantine, donates plasma in the city's blood center in Wuhan in central China's Hubei province. Plasma from recovered COVID-19 patients contains antibodies that may help reduce the viral load in patients that are fighting the disease. (Chinatopix via AP, File). Chinatopix via AP, File

Smaller font Descrease article font size -A

Larger font Increase article font size A +

A clinical trial for a potential treatment for COVID-19 is now underway in Edmonton and Calgary.

In the trial, convalescent plasma is taken from patients who have recovered from COVID-19. That plasma, which contains antibodies to the virus, is then transferred to patients who are being hospitalized for the illness but have not yet been intubated.

“Providing these passive antibodies to patients, we hope will improve their survival and actually prevent them from developing severe disease,” said Dr. Wendy Sligl, a co-investigator in the clinical trial. She is also an infectious diseases and critical care physician at the University of Alberta Hospital.

The convalescent plasma trial, also called CONCOR, is being coordinated nationwide by the Canadian Blood Services and is being overseen in Alberta by Dr. Susan Nahirniak, a transfusion medicine physician. It officially started approximately two weeks ago.

Story continues below advertisement

Source: https://globalnews.ca/news/7240801/edmonton-covid-19-treatment-clinical-trial/

Continue reading

Nobody has rated this post!
Vote now!
Cumulative results: 0 points • Rating: 0.000